research use only

Ribupatide

Cat.No.P1274

Ribupatide (HRS9531) is an oral dual GLP‑1/GIP receptor agonist that demonstrates potent glycemic control and clinically meaningful weight‑loss efficacy in obesity and type 2 diabetes trials.

Amino-acid Sequence

CAS No. 2940971-65-1

Quality Control

Batch: P127401 DMSO] 100 mg/mL] false] Water] Insoluble] false] Ethanol] Insoluble] false Purity: 96.08%

96.08

Featured Inhibitors	Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933

Chemical Information & Solubility

Storage (From the date of receipt)	3 years-20°Cpowder	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
			1 month-20°Cin solvent

In vitro
Batch:

DMSO : 100 mg/mL ；
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Biological Activity

Description	Ribupatide (HRS9531) is an oral dual GLP‑1/GIP receptor agonist that demonstrates potent glycemic control and clinically meaningful weight‑loss efficacy in obesity and type 2 diabetes trials.

References
https://diabetesjournals.org/diabetes/article/74/Supplement_1/797-P/158958

References

https://diabetesjournals.org/diabetes/article/74/Supplement_1/797-P/158958

Product Information

Molecular Formula	C₂₂₉H₃₄₆N₄₈O₇₁
CAS No.	2940971-65-1
Shipping	Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)